A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if ixabepilone plus bevacizumab is
effective in shrinking or stopping the growth of cancer when given as first-line chemotherapy
in participants with metastatic breast cancer. The study will also assess the safety of this
combination treatment.